KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Common Equity (2016 - 2025)

Xylem has reported Common Equity over the past 16 years, most recently at $11.5 billion for Q4 2025.

  • Quarterly results put Common Equity at $11.5 billion for Q4 2025, up 7.93% from a year ago — trailing twelve months through Dec 2025 was $11.5 billion (up 7.93% YoY), and the annual figure for FY2025 was $11.5 billion, up 7.93%.
  • Common Equity for Q4 2025 was $11.5 billion at Xylem, up from $11.2 billion in the prior quarter.
  • Over the last five years, Common Equity for XYL hit a ceiling of $11.5 billion in Q4 2025 and a floor of $2.9 billion in Q1 2021.
  • Median Common Equity over the past 5 years was $9.9 billion (2023), compared with a mean of $7.3 billion.
  • Biggest five-year swings in Common Equity: skyrocketed 209.4% in 2023 and later grew 4.42% in 2024.
  • Xylem's Common Equity stood at $3.2 billion in 2021, then grew by 8.59% to $3.5 billion in 2022, then skyrocketed by 190.49% to $10.2 billion in 2023, then increased by 4.63% to $10.6 billion in 2024, then increased by 7.93% to $11.5 billion in 2025.
  • The last three reported values for Common Equity were $11.5 billion (Q4 2025), $11.2 billion (Q3 2025), and $11.1 billion (Q2 2025) per Business Quant data.